Browsing: GLP1

A recent Gallup poll reveals a significant increase in the use of GLP-1 medications for weight loss among Americans. As of 2026, 11% of Americans are using these drugs, a notable rise from just 3% in 2024. This surge in usage is linked to a gradual decline in the U.S. adult obesity rate, which has…

The new Medicare GLP-1 Bridge program offers broader, more affordable access to weight loss drugs to address the growing obesity crisis. But there’s a catch when it comes to bone health

With the proliferation of telehealth websites, Yale researchers were curious how much oversight is required to get GLP-1 weight-loss drugs. To find out, one of the researchers, posing as an overweight man, started shopping around

Partners Hengrui Pharma and Kailera Therapeutics revealed Tuesday that two China-based late-stage trials evaluating an investigational small molecule GLP-1 receptor have hit their main goals, prompting Hengrui to tee up plans for regulatory submission in the Asian country

HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) exposures reported to U.S. poison centers increased following 2021 U.S. Food and Drug Administration (FDA) approval for weight loss, according to a study published in the April issue of the Journal of Medical Toxicology

What began as a treatment for type 2 diabetes has rapidly evolved into one of the biggest shifts in modern healthcare. New data suggests that GLP-1 medications, popularly associated with brands such as Ozempic and Wegovy, are no longer confined to celebrity headlines or specialist clinics but have entered the mainstream

GLP-1 medications, with brand names such as Ozempic, Wegovy, and Zepbound, regulate blood sugar in people with type 2 diabetes and are also used for weight loss. Over the years, studies have shown them to be safe and effective when taken as prescribed

Iowa — Hy-Vee, Inc. is rolling out a new GLP-1 wellness program aimed at helping patients on the popular weight-loss and diabetes medications get more out of their treatment through better nutrition and side-effect management, the grocery chain announced Monday